Understanding the Mechanisms of Neuropathogenesis

了解神经发病机制

基本信息

项目摘要

DESCRIPTION (provided by applicant): The long-term goal of this research program is to understand the biochemical pathways that regulate age-dependent neuronal viability in metazoans. Using a tractable genetic system to elucidate these pathways and uncover the mechanisms by which they contribute to neurodegenerative diseases and normal senescence, are important goals of my research. We have isolated a number of mutants in an unbiased forward genetic screen that provide us a novel perspective with which to study neuronal senescence and neurodegeneration in vivo. This proposal focuses on mutations that affect ATPalpha (Na/K ATPase), which cause progressive neurodegeneration in Drosophila. In humans loss-of-function Na/K ATPase mutations cause Rapid-onset Dystonia Parkinsonism (RDP) and familial hemiplegic migraines (FHM). Na/K ATPase activity is reduced after ischemia and traumatic brain injury, and is associated with Alzheimer's disease. We hypothesize that neuropathogenesis is mechanistically similar in our mutants and patients with neurological diseases, including RDP and FHM, and propose experiments to elucidate these mechanistic details. Additionally, we propose to identify mutations capable of suppressing the underlying dysfunction and neurodegeneration. We will study these mutants using genetic, molecular, cell biological, and biochemical techniques to elucidate the mechanisms by which the mutations lead to cellular dysfunction and discover how this dysfunction manifests as neurological phenotypes, such as paralysis, seizures and progressive neurodegeneration. Together these specific experiments will elucidate the mechanisms of neuropathogenesis in ATPalpha mutants and lead to a better understanding of age-related neurodegeneration and senescence.
描述(由申请人提供):该研究计划的长期目标是了解调节后生动物年龄依赖性神经元活力的生化途径。使用易于处理的遗传系统来阐明这些途径并揭示它们导致神经退行性疾病和正常衰老的机制,是我研究的重要目标。我们在无偏正向遗传筛选中分离出了许多突变体,这为我们研究体内神经元衰老和神经变性提供了新的视角。该提案重点关注影响 ATPα(Na/K ATP 酶)的突变,该突变会导致果蝇进行性神经变性。在人类中,功能丧失的 Na/K ATP 酶突变会导致快速发作的肌张力障碍性帕金森症 (RDP) 和家族性偏瘫性偏头痛 (FHM)。 Na/K ATP酶活性在缺血和创伤性脑损伤后降低,并且与阿尔茨海默病有关。我们假设我们的突变体和神经系统疾病(包括 RDP 和 FHM)患者的神经发病机制在机制上相似,并提出实验来阐明这些机制细节。此外,我们建议鉴定能够抑制潜在功能障碍和神经变性的突变。我们将使用遗传、分子、细胞生物学和生化技术研究这些突变体,以阐明突变导致细胞功能障碍的机制,并发现这种功能障碍如何表现为神经表型,如瘫痪、癫痫发作和进行性神经变性。这些具体的实验将共同阐明 ATPα 突变体的神经发病机制,并导致更好地了解与年龄相关的神经变性和衰老。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael John Palladino其他文献

Michael John Palladino的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael John Palladino', 18)}}的其他基金

Developing the first TPI Df therapeutics
开发第一个 TPI Df 疗法
  • 批准号:
    10393677
  • 财政年份:
    2021
  • 资助金额:
    $ 28.97万
  • 项目类别:
Developing the first TPI Df therapeutics
开发第一个 TPI Df 疗法
  • 批准号:
    10613470
  • 财政年份:
    2021
  • 资助金额:
    $ 28.97万
  • 项目类别:
Developing the first TPI Df therapeutics
开发第一个 TPI Df 疗法
  • 批准号:
    10229007
  • 财政年份:
    2021
  • 资助金额:
    $ 28.97万
  • 项目类别:
Developing a murine TPI Df model
开发小鼠 TPI Df 模型
  • 批准号:
    10294798
  • 财政年份:
    2021
  • 资助金额:
    $ 28.97万
  • 项目类别:
High-content screening for TPI Deficiency therapeutics
TPI 缺乏疗法的高内涵筛选
  • 批准号:
    10662471
  • 财政年份:
    2021
  • 资助金额:
    $ 28.97万
  • 项目类别:
High-content screening for TPI Deficiency therapeutics
TPI 缺乏疗法的高内涵筛选
  • 批准号:
    10312211
  • 财政年份:
    2021
  • 资助金额:
    $ 28.97万
  • 项目类别:
Genetic modulation of mitochondrial function
线粒体功能的遗传调节
  • 批准号:
    9542442
  • 财政年份:
    2018
  • 资助金额:
    $ 28.97万
  • 项目类别:
Pre-clinical studies of novel mitochondrial gene therapies
新型线粒体基因疗法的临床前研究
  • 批准号:
    9036405
  • 财政年份:
    2015
  • 资助金额:
    $ 28.97万
  • 项目类别:
Determining the cellular and molecular basis of mitochondrial encephalomyopathy seizures
确定线粒体脑肌病癫痫发作的细胞和分子基础
  • 批准号:
    9150332
  • 财政年份:
    2015
  • 资助金额:
    $ 28.97万
  • 项目类别:
Pre-clinical studies of novel mitochondrial gene therapies
新型线粒体基因疗法的临床前研究
  • 批准号:
    9411127
  • 财政年份:
    2015
  • 资助金额:
    $ 28.97万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 28.97万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 28.97万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 28.97万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 28.97万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 28.97万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 28.97万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 28.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 28.97万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 28.97万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 28.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了